DURHAM A biotechnology company based in downtown Durham has filed plans to go public — a move that could net the company around $100 million. Precision BioSciences, which has offices at the historic Venable Center in downtown Durham, filed plans on March 1 with the Securities and Exchange Commission for an initial public offering on the Nasdaq stock exchange. The company would trade under the ticker symbol “DTIL,” according to the filing. The company, which has around 130 employees, is developing a genome editing platform called ARCUS, which the company hopes to use to treat diseases such as cancer, as … Continue reading Precision Biosciences hoping to raise $100 million through an IPO